Article PDF


brain injury, carbacetam, neurospecific proteins S-100B, NSE, GFAP

Abstract views: 184
PDF Downloads: 165

How to Cite

Ziablytsev, S., Panova, T., Starodubska, O., & Dyadik, O. (2018). EXPERIMENTAL INVESTIGATION ON CARBACETAM INFLUENCE ON HYPOTHALAMUS TISSUE IN BRAIN INJURY. Medical Science of Ukraine (MSU), 14(1-2), 11-17. https://doi.org/10.32345/2664-4738.1-2.2018.02


Relevance. A key role in the pathogenesis of the brain injury is played by destructive changes in the hypothalamus neuroendocrine cells. For the correction of such disorders, promising is carbacetam, which has antihypoxic, anti-edema and anti-shock effects.

Objective: to investigate the effect of carbacetam on the processes of neurodegeneration in the paraventricular and supraoptical nuclei of the hypothalamus in the experimental brain injury.

Material and methods. Brain injury were modeled on the V.M. Elskyy &S.V. Ziablitsev model on white non-breeding male rats weighing 200±10 g. Experimental animals (n=10) received intraabdominal injection of carbacetam at a dose of 5 mg/kg in 1 ml of physiological saline during the seven days after injury. In the control group (n=10), 1 ml of physiological saline was injected. Hypothalamic tissue microparticles performed a morphological and immunohistochemical evaluation of neurodegenerative changes when stained with hematoxylin and eosin and immunohistochemically to detect NSE, S-100 and GFAP neuromarkers.

Results. Carbacetam reduced the degenerative processes in the nervous tissue of the paraventricular and supraoptical nuclei of the hypothalamus, which was manifested by the restoration of normal morphological features, in contrast to rats that did not receive the drug. Immunohistochemically, GFAP and S-100 glial markers exhibited reduced, reflecting a reduction in degenerative changes in the nerve tissue. Expressions of the neurons marker NSE increased, reflecting high metabolic activity of the neurons.

Conclusions. Revealed changes in the expression of markers of neurons and glia showed a restoration of normal neuronal activity due to the introduction of carbacetam.

Article PDF


Chvatal А., Anderova M., Neprasova H. Pathological Potential of Astroglia // Physiol. Res. 2008. Vol. 57, Suppl. 3. P. 101-110.

Dulenko, V.I., Komissarov, I.V., Doljenko, A.T., & Nikolukin, U.A. β-Carbolini. Himia i neirobiologia [β-Carbolines. Chemistry and Neurobiology]. Kiev: Nauk. Dumka. 1992. [in Russian].

Elskyy, V.N., & Ziablitsev, S.V. Modelirovanie cherepno-mozgovoj travmy [Design of brain injury]. Donetsk: Publishing by “New World”. 2008. [in Russian].

Kibalny A.V., Dulenko V.I., Khabarov K.M. New high-effective neuroprotector – carbacetam // Drugs of the future. Brussel. Suppl. A. 2010. Vol. 35. P. 198.

Li M., Zhao Z., Yu G., Zhang J. Epidemiology of Traumatic Brain Injury over the World: A Systematic Review // Gen. Med. (Los Angel). 2016. Vol. 4, № 5. Р. 1-13.

Maia P.D., KutzJ.N. Reaction time impairments in decision-making networks as a diagnostic marker for traumatic brain injuries and neurological diseases // J. Comput. Neurosci. 2017. Vol. 42, № 3. Р. 323-347. doi: 10.1007/s10827-017-0643-y.

Semenov S.N., Polyakova N.D., Dolgopolova T.V. Ultrastrukturnaya harakteristika krupnokletochnyih yader gipotalamusa i neyrogipofiza kryis pri prolongirovannoy alkogolnoy intoksikatsii i vvedenii α-tokoferola // Zhurnal anatomii i gistopatologi. 2012. Т. 1, № 1. S. 65-73 [in Russian].

Singh H.V., Singh H.V., Pandey A., Shrivastava A.K. et al. Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit // Clin. Chim. Acta. 2013. Vol. 419. P. 136-138. doi: 10.1016/j.cca.2013.02.014.

Vedunova M.V., Terentieva K.A., Shchelchkova N.A. et al. Determining Concentration of Neurotrophic Factors and Neuron specific Enolase in the blood of Newborns with Central Nervous system Damages as a New Approach in Clinical Diagnostics // СТМ. 2015. Vol. 7, № 2. Р. 25-30.

Wolf H., Frantal S., Pajenda G.S. et al. Predictive value of neuromarkers supported by a set of clinical criteria in patients with mild traumatic brain injury: S100B protein and neuron-specific enolase on trial: clinical article // J. Neurosurg. 2013. Vol. 118, № 6. Р. 1298-1303. doi: 10.3171/2013.1.JNS121181.

Yardimoglu M., Ilbay G., Dalcik C. et al. Immunocytochemistry of neuron specific enolase (NSE) in the rat brain after single and repeated epileptic seizures // Int. J. Neurosci. 2008. Vol. 118, № 7. Р. 981-993. doi: 10.1080/00207450701769232.

Ziablitsev S.V., Starodubska O.O. Condition of neuro-hormonal systems in traumatic brain injury and influence of Carbacetam // Kiev: Pathology, 2017 [in Ukrainian].

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.